Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

Samsung Q1 Profit to Drop 21% Amid Weak AI Chip Sales and Foundry Losses

by Team Lumida
April 7, 2025
in AI
Reading Time: 4 mins read
A A
0
Samsung signage

Photo by Kote Puerto on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Samsung Electronics is expected to report a 21% decline in Q1 operating profit to 5.2 trillion won ($3.62 billion), down from 6.6 trillion won a year ago.
  • Weak AI chip sales and continued losses in its contract chip manufacturing (foundry) business are the primary drivers of the decline.
  • Falling DRAM and NAND flash memory prices, coupled with U.S. tariffs on consumer electronics, are adding to Samsung’s challenges.
  • Samsung’s mobile and network business is expected to post a slight profit increase to 3.7 trillion won, supported by higher smartphone shipments and favorable currency effects.

What Happened?

Samsung Electronics is grappling with a challenging quarter as its Q1 operating profit is projected to fall 21% year-over-year. The company’s chip division, which has been underperforming since mid-2024, continues to struggle with weak demand for high-performance AI chips and declining DRAM and NAND flash memory prices.

Samsung’s reliance on less advanced memory chips for Chinese customers, who are facing U.S. export restrictions, has further hurt profitability. Meanwhile, its foundry business remains in the red, with the start-up of its new U.S. factory delayed to 2027 due to a lack of major production orders.

Adding to the pressure, U.S. tariffs on consumer electronics are expected to raise costs for Samsung’s products, including smartphones, TVs, and home appliances, potentially dampening consumer demand.


Why It Matters?

Samsung’s struggles highlight the challenges faced by global tech giants in navigating a volatile market shaped by geopolitical tensions, trade policies, and shifting consumer demand. The company’s underperformance in the AI chip market, where rival SK Hynix is thriving, underscores the importance of innovation and high-end product offerings in maintaining competitiveness.

The impact of U.S. tariffs on Samsung’s consumer electronics business further complicates its outlook, as higher costs could erode demand and profitability. Meanwhile, delays in its U.S. foundry operations signal ongoing challenges in diversifying its production base and securing major clients.


What’s Next?

Samsung is working on a redesigned version of its advanced HBM chips to regain competitiveness in the AI chip market. However, analysts expect the company’s profitability to remain under pressure in the near term due to volatile memory prices and geopolitical headwinds.

The company may also explore diversifying its production base as part of its long-term strategy to mitigate the impact of tariffs, though such efforts will take years to materialize. Investors will be closely watching Samsung’s Q1 earnings report on Tuesday for further insights into its recovery plans and market outlook.

Source
Previous Post

Tether CEO Paolo Ardoino Discusses the Stablecoin Giant’s Profitable Business and Controversies

Next Post

Emerging Drugs from Lilly, Amgen, and Novartis Target Untreatable Cholesterol Linked to Heart Disease

Recommended For You

Anthropic to Tell Investors It Sees $30 Trillion in Potential Revenue — Topping Even SpaceX

by Team Lumida
1 day ago
Pentagon–Anthropic Feud Escalates as AI Policy Clash Threatens Defense Contracts

Anthropic is expected to tell investors its potential revenue opportunity exceeds $30 trillion, surpassing SpaceX's record-breaking $28.5 trillion estimate. The figure reflects Anthropic's view of AI's total addressable...

Read more

OpenAI’s Head of Data Centers Has Left — Another Senior Departure Ahead of Its IPO

by Team Lumida
1 day ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Chris Malone, OpenAI's head of data centers who oversaw the company's Stargate buildout, left last week — joining a growing wave of senior departures as OpenAI prepares for...

Read more

Nvidia Has Become the Banker to the AI Boom — and That Creates a New Risk

by Team Lumida
2 days ago
Nvidia’s AI Demand Surge: Hon Hai Ramps Up Server Production

Nearly four years into an AI boom that has generated hundreds of billions in profit, Nvidia is increasingly using its financial strength to provide financing to customers buying...

Read more

Alibaba Raises $10.2 Billion in Hong Kong’s Biggest Share Sale Since 2021 to Fund AI Arms Race

by Team Lumida
3 days ago
Why Alibaba’s $2.8 Billion AI Investment Could Shake Up the Market

Alibaba sold 710 million shares in a HK$80 billion ($10.2 billion) follow-on offering — Hong Kong's largest since 2021 — despite an 8.5% stock drop on the day,...

Read more

Amazon Enters the Robotaxi Race: Zoox’s Driverless, Steering-Wheel-Free Pods Are Now Charging for Rides

by Team Lumida
3 days ago
Amazon Enters the Robotaxi Race: Zoox’s Driverless, Steering-Wheel-Free Pods Are Now Charging for Rides

Amazon's Zoox has become the first company to offer paid robotaxi rides in a vehicle with no steering wheel, dashboard, or pedals — a bidirectional all-electric pod seating...

Read more

DeepSeek Adds Vision to Its Flagship Model, Claiming Performance Close to Anthropic’s Opus 4.8

by Team Lumida
6 days ago
A person holding a cell phone in their hand

DeepSeek released an experimental multimodal version of its V4 Flash model that can analyze images and screenshots — claiming performance "close to" Anthropic's advanced Opus 4.8 on agentic...

Read more

AI Investment Boom Lifts US Growth Outlook as Fed Stays Cautious on Rate Cuts

by Team Lumida
6 days ago
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Economists raised their Q3 GDP forecast to 2.5% annualized — up from 2% — driven by AI-fueled capital expenditure that may exceed $1 trillion this year and resilient...

Read more

China’s AI Is Closing In on America’s Best — and Winning on Price, Adoption, and Open-Source Strategy

by Team Lumida
7 days ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

A Bloomberg Businessweek analysis finds China rapidly closing the AI capability gap with the U.S., with Moonshot's Kimi K3 nearly matching Anthropic's most advanced models at less than...

Read more

OpenAI’s Q2 Revenue Rose 18% to $6.7B — But Losses Deepened and Investors Are Comparing It Unfavorably to Anthropic

by Team Lumida
1 week ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

OpenAI reported $6.7 billion in Q2 revenue, up 18% sequentially from $5.7 billion in Q1, but its operating margin worsened further into the red — disappointing investors who...

Read more

Inside the Race to Build America’s First New Nuclear Reactor in a Generation — and Why AI Is Driving It

by Team Lumida
1 week ago
AI’s Power Play: How Nuclear Energy Fuels Data Centers

Nuclear startup Oklo is breaking ground at Idaho National Laboratory on one of America's first new reactors in decades, as renewed interest in atomic energy collides with insatiable...

Read more
Next Post
white and blue medication pill blister pack

Emerging Drugs from Lilly, Amgen, and Novartis Target Untreatable Cholesterol Linked to Heart Disease

Donald Trump beside man in black suit

Trump Demands Trade Deficit Resolution Before Any Deal With China Amid Global Market Turmoil

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Kamala Harris’s Business Record: A Double-Edged Sword for Investors

Kamala Harris’s Business Record: A Double-Edged Sword for Investors

July 29, 2024
Illumina Faces Mounting Challenges Amid Trade War, Competition, and Policy Shifts

Illumina Faces Mounting Challenges Amid Trade War, Competition, and Policy Shifts

February 24, 2025
China’s Golden Week: Why Spending Still Trails Pre-Covid Levels

China’s Golden Week: Why Spending Still Trails Pre-Covid Levels

October 9, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018